{"id":"NCT02991482","sponsor":"ETOP IBCSG Partners Foundation","briefTitle":"PembROlizuMab Immunotherapy Versus Standard Chemotherapy for Advanced prE-treated Malignant Pleural Mesothelioma","officialTitle":"A Multicentre Randomised Phase III Trial Comparing Pembrolizumab Versus Standard Chemotherapy for Advanced Pre-treated Malignant Pleural Mesothelioma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-09-12","primaryCompletion":"2019-02-20","completion":"2021-11-30","firstPosted":"2016-12-13","resultsPosted":"2022-02-07","lastUpdate":"2022-08-24"},"enrollment":144,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Pleural Mesothelioma Malignant Advanced"],"interventions":[{"type":"DRUG","name":"Pembrolizumab","otherNames":["KEYTRUDA","MK-3475","SCH 900475"]},{"type":"DRUG","name":"Gemcitabine","otherNames":["Gemzar"]},{"type":"DRUG","name":"Vinorelbine","otherNames":["Navelbine"]}],"arms":[{"label":"Pembrolizumab arm","type":"EXPERIMENTAL"},{"label":"Standard chemotherapy arm","type":"ACTIVE_COMPARATOR"}],"summary":"Trial comparing standard treatment (chemotherapy) with pembrolizumab treatment in patients with advanced pretreated malignant mesothelioma.","primaryOutcome":{"measure":"Progression Free Survival (PFS) as Assessed by Independent Radiological Review","timeFrame":"Time from randomization of the first patient until database cutoff date for the primary PFS analysis (Sep 2017 - Feb 2019; approximately 1.5 years).","effectByArm":[{"arm":"Pembrolizumab Arm","deltaMin":2.5,"sd":null},{"arm":"Standard Chemotherapy Arm","deltaMin":3.4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.76"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":19,"exclusionCount":19},"locations":{"siteCount":15,"countries":["Spain","Switzerland","United Kingdom"]},"refs":{"pmids":["26712084","16054941","18227828","19259084","17534390","12860938","25800891"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":25,"n":72},"commonTop":["Fatigue","Diarrhea","Constipation","Nausea","Pain"]}}